The stock of Ginkgo Bioworks Holdings Inc (DNA) has gone up by 12.46% for the week, with a -14.99% drop in the past month and a -44.45% drop in the past quarter. The volatility ratio for the week is 14.14%, and the volatility levels for the past 30 days are 9.67% for DNA. The simple moving average for the past 20 days is -3.73% for DNA’s stock, with a -33.52% simple moving average for the past 200 days.
Is It Worth Investing in Ginkgo Bioworks Holdings Inc (NYSE: DNA) Right Now?
The stock has a 36-month beta value of 1.19. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 1 as “sell.”
The public float for DNA is 36.98M, and at present, short sellers hold a 26.98% of that float. On April 08, 2025, the average trading volume of DNA was 1.65M shares.
DNA) stock’s latest price update
Ginkgo Bioworks Holdings Inc (NYSE: DNA) has experienced a rise in its stock price by 15.08 compared to its previous closing price of 5.57. However, the company has seen a gain of 12.46% in its stock price over the last five trading days. youtube.com reported 2025-04-06 that As 23AndMe files for bankruptcy, customers are left wondering what happens to their DNA data? On this episode of the Big Take podcast, we discuss what this means for millions of users’ genetic data and for the future of the genetic testing industry.
Analysts’ Opinion of DNA
Raymond James gave a rating of “Mkt Perform” to DNA, setting the target price at $2.50 in the report published on November 14th of the previous year.
DNA Trading at -32.79% from the 50-Day Moving Average
After a stumble in the market that brought DNA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -86.53% of loss for the given period.
Volatility was left at 9.67%, however, over the last 30 days, the volatility rate increased by 14.14%, as shares sank -7.77% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -50.00% lower at present.
During the last 5 trading sessions, DNA rose by +12.46%, which changed the moving average for the period of 200-days by -61.94% in comparison to the 20-day moving average, which settled at $6.66. In addition, Ginkgo Bioworks Holdings Inc saw -34.73% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DNA starting from Che Austin, who proposed sale 99 shares at the price of $5.16 back on Apr 07 ’25. After this action, Che Austin now owns shares of Ginkgo Bioworks Holdings Inc, valued at $511 using the latest closing price.
Che Austin, the Officer of Ginkgo Bioworks Holdings Inc, proposed sale 99 shares at $5.50 during a trade that took place back on Apr 04 ’25, which means that Che Austin is holding shares at $544 based on the most recent closing price.
Stock Fundamentals for DNA
Current profitability levels for the company are sitting at:
- -2.38 for the present operating margin
- 0.68 for the gross margin
The net margin for Ginkgo Bioworks Holdings Inc stands at -2.41. The total capital return value is set at -0.43. Equity return is now at value -60.34, with -35.96 for asset returns.
Based on Ginkgo Bioworks Holdings Inc (DNA), the company’s capital structure generated 0.38 points at debt to capital in total, while cash flow to debt ratio is standing at -0.73. The debt to equity ratio resting at 0.61. The interest coverage ratio of the stock is -5749.91.
Currently, EBITDA for the company is -484.39 million with net debt to EBITDA at 0.26. When we switch over and look at the enterprise to sales, we see a ratio of 1.1. The receivables turnover for the company is 10.39for trailing twelve months and the total asset turnover is 0.16. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.62.
Conclusion
To sum up, Ginkgo Bioworks Holdings Inc (DNA) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
